跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 45 条关于
“TRIMTAC”
全部
45
临床试验
26
药物
12
机构
0
资讯
7
9个月前
Convergen Raises $10 Million to Advance Novel TrimTAC Platform Targeting Neurodegenerative Disease Protein Aggregates
去年
TRIMTECH Therapeutics Secures $31M Seed Funding for Novel Protein Degradation Platform Targeting Neurodegenerative Diseases
2个月前
TRIMTECH Therapeutics Secures $14M Extension, Bringing Total Seed Round to $47M for Targeted Protein Degradation in Neurodegenerative Disease
上个月
Marengo Nominates First TriSTAR Drug Candidate with Ipsen, Appoints T-Cell Engager Expert Saso Cemerski
去年
First Patient Dosed in Novel RIPTAC Cancer Therapy Trial for Advanced Prostate Cancer
去年
Halda Therapeutics to Present RIPTAC Cancer Therapies at J.P. Morgan Healthcare Conference
去年
Halda Therapeutics Appoints Dr. Eyal Attar as Chief Medical Officer to Advance Novel RIPTAC Cancer Platform